ARTKQTARKSTGGKAPRKQLA

Product Name
ARTKQTARKSTGGKAPRKQLA
Product Quantity
5 mg
Catalog Number
5924
Category
Peptide
Sequence
ARTKQTARKSTGGKAPRKQLA, C-ARTKQTARKSTGGKAPRKQLA, and Alexa647-C-ARTKQTAR-{Lys(Me3)}-STGGKA are available upon request.
Purity
>95%
Product Description

The peptide sequence ARTKQTARKSTGGKAPRKQLA corresponds to the N-terminal tail of histone H3, a core component of the nucleosome in eukaryotic chromatin. This region is subject to various post-translational modifications (PTMs), such as methylation and acetylation, which play crucial roles in regulating gene expression by altering chromatin structure and recruiting specific protein complexes.

Function and Biological Importance:

  • Epigenetic Regulation: Modifications on the histone H3 tail, particularly at lysine residues like K4, K9, and K27, serve as signals for the activation or repression of gene transcription. For instance, trimethylation at H3K4 is commonly associated with active gene promoters, while trimethylation at H3K27 is linked to gene silencing.

  • Chromatin Dynamics: The PTMs on this peptide sequence influence nucleosome stability and positioning, thereby affecting DNA accessibility for transcription factors and other DNA-binding proteins.

  • Cellular Processes: Through its role in chromatin remodeling, the histone H3 N-terminal tail is integral to processes such as DNA replication, repair, and cell cycle progression.

Applications:

  • Research Tools: Synthetic peptides mimicking this sequence are utilized in studies to investigate the effects of specific histone modifications on protein interactions and chromatin behavior.

  • Therapeutic Targets: Enzymes that modify histone tails, such as histone methyltransferases and deacetylases, are being explored as targets for drug development in diseases where epigenetic regulation is disrupted, including cancer.

Understanding the modifications and interactions of the histone H3 N-terminal tail is essential for elucidating the mechanisms of gene regulation and the development of epigenetic therapies.

Scientific Background

ARTKQTARKSTGGKAPRKQLA is a 21-residue synthetic peptide with the sequence Ala-Arg-Thr-Lys-Gln-Thr-Ala-Arg-Lys-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-Lys-Gln-Leu-Ala. The sequence contains 4 Lys and 3 Arg residues, contributing cationic character. These sequence-derived properties describe the reagent chemically; no specific receptor, enzyme, pathway, disease association, or biological activity is assigned without product-specific experimental evidence.

Research Applications
  • LC-MS/HPLC analytical method development
  • sequence-specific assay controls
Experimental Notes

Sequence-derived chemical properties support reagent selection and experimental planning but do not establish biological function. Solubility, aggregation, adsorption, conjugation efficiency, and assay performance should be validated under the intended experimental conditions.

  • 30 Units in Stock
Ask a Question

$350.00

Add to Cart: